The deal will see Mediclinic Holdings divest its Swiss operations, the Hirslanden group, to Investment Holding Limited (IHL), a unit of MSC Mediterranean Shipping Company. At the same time, Remgro will acquire all shares in Mediclinic Southern Africa.
Both legs of the transaction will be executed simultaneously on a 1:1 value exchange basis, with a long-stop date set for September 30, 2027. If one part of the deal is completed and the other fails, the affected party will compensate the other in cash.
Remgro and IHL each currently hold a 50% stake in Mediclinic Holdings. Once the restructuring is completed, both partners will take full control of their respective regional businesses while retaining joint interests in the Middle East through the EHH Group and in the UK via Spire Healthcare.
Restructuring to Drive Growth
The restructuring is expected to improve operational focus and strengthen relationships with patients, clinicians, and regulators, particularly in South Africa. It also positions both companies to pursue more targeted growth strategies in their core markets.
Mediclinic Southern Africa is the third-largest private healthcare provider in the region by licensed beds.
Its portfolio also includes the Intercare group and ER24 emergency medical services, both of which will become fully owned by Remgro upon the deal’s closure.
It currently operates 50 hospitals, 15 day clinics, six sub-acute facilities, and six mental health centres across South Africa, along with three private hospitals in Namibia, providing over 8,991 beds and employing more than 21,000 people.
Remgro’s ties to Mediclinic date back decades to the Rembrandt Group, founded by Anton Rupert. In 2023, Remgro and MSC jointly acquired Mediclinic in a deal valued at about R75 billion, taking the company private after listings in Johannesburg and London.
The transaction remains subject to regulatory approvals in South Africa and Switzerland. Despite the split, both parties will continue to collaborate in the Middle East, a key growth market that has supported Mediclinic’s recent strong financial performance.